Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 24
Phase 41

Trial Status

Completed5
Terminated1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT01996826Phase 1/2Completed
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Corneal Graft FailureCorneal Neovascularization
PrincipalinvestigatorStart date: 2014-04-01
NCT01456780Phase 4Completed
Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Meibomian Gland DysfunctionPosterior Blepharitis
PrincipalinvestigatorStart date: 2011-08-01
NCT00681109Phase 1/2Completed
Topical IL-1-Ra for Treatment of Posterior Blepharitis
Posterior Blepharitis
Principalinvestigator
NCT00915590Phase 1/2Terminated
Topical IL-1-Ra for Treatment of Corneal Neovascularization
Corneal Neovascularization
Principalinvestigator
NCT01072357Phase 1/2Completed
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Corneal Graft FailureCorneal Neovascularization
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT01996826Phase 1/2PrincipalInvestigator

A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Corneal Graft FailureCorneal Neovascularization
Completed
NCT01456780Phase 4PrincipalInvestigator

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis

Meibomian Gland DysfunctionPosterior Blepharitis
Completed
NCT00681109Phase 1/2PrincipalInvestigator

Topical IL-1-Ra for Treatment of Posterior Blepharitis

Posterior Blepharitis
Completed
NCT00915590Phase 1/2PrincipalInvestigator

Topical IL-1-Ra for Treatment of Corneal Neovascularization

Corneal Neovascularization
Terminated
NCT01072357Phase 1/2PrincipalInvestigator

Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival

Corneal Graft FailureCorneal Neovascularization
Completed
NCT01977781Phase 1PrincipalInvestigator

Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

Ocular GVHD
Completed

All 6 trials loaded